Prothena Corp Public (PRTA) Other Operating Expenses (2018 - 2026)
Prothena Corp Public's (PRTA) quarterly Other Operating Expenses came in at -$4.2 million in Q1 2026, down 41.09% quarter-over-quarter from -$3.0 million in Q4 2025.
Prothena Corp Public (PRTA) Other Operating Expenses (2018 - 2026) Analysis & Trends
Prothena Corp Public's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$4.2 million for Q1 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was $25.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $30.1 million, changed N/A from the prior year.
- Other Operating Expenses slipped to -$4.2 million in Q1 2026 per PRTA's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $32.6 million in Q2 2025 and bottomed at -$4.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.24 Mn |
| Dec 31, 2025 | -3.01 Mn |
| Sep 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 32.61 Mn |
| Mar 31, 2019 | -61,000.00 |
| Dec 31, 2018 | -1.59 Mn |
| Sep 30, 2018 | -3.17 Mn |
| Jun 30, 2018 | 20.90 Mn |